March 10, 2023 – The rapid transition from in-person to care to telemedicine visits at the start of the COVID‑19 pandemic did not adversely affect the quality of care – and even improved some aspects of care – for patients with major depression in a major integrated health system, according to a new report. The study appears as part of a special “Virtual Visits” supplement to Medical Care, published in the Lippincott portfolio by Wolters Kluwer.
“A rapid shift to virtual behavioral health care was possible without compromising health care-related practices,” according to the new research, led by Nancy S. Weinfield, PhD, of Kaiser Permanente (KP) Mid-Atlantic Permanente Research Institute, Rockville, Md. The study is one of 10 original research papers examining the implementation and impact of telemedicine in the new supplement, sponsored by KP.
New research on telemedicine implementation in health care systems
In March 2020, health care systems across the United States rapidly pivoted from in-person appointments to virtual visits via telemedicine. While many providers had been building their telemedicine capabilities, the unprecedented shift to virtual visits during the pandemic had the potential to disrupt care practices and outcomes – perhaps especially in vulnerable patient groups.
The new studies look at how the shift to telemedicine affected the quality, utilization, and patient experience of care. “The supplemental issue of Medical Care aims to advance evidence about how health care organizations and systems can best support telemedicine implementation,” according to an introduction by Guest Editor Hector P. Rodriguez, PhD, MPH, of University of California, Berkeley.
Seven papers assess the implementation of telemedicine within three regions of the KP system, examining trends in telemedicine utilization, and comparing the impact of telemedicine and in-person visits on conditions including urinary tract infections, neck and back pain, and depression. Other studies focus on vulnerable populations, including Medicare and Medicaid beneficiaries and patients receiving care in community health centers – highlighting telemedicine’s role in maintaining continuity of primary care and the quality of diabetes care.
Virtual visits persist for major depression, and some aspects of care improve
In their study, Dr. Weinfield and colleagues looked at how the shift to virtual visits in the KP system affected care for patients with depression. The researchers analyzed electronic health record data on nearly 29,000 first telemedicine follow-up behavioral health visits by patients diagnosed with major depression.
Two of three KP regions showed small but significant reductions in prescriptions for antidepressant medications during the peak pandemic shift to virtual care (April to June 2020), after adjustment for patient characteristics. However, medication orders returned to pre-pandemic levels during the recovery period, beginning in the summer of 2020. Prescription fulfillment rates were unchanged between the three periods.
Meanwhile, rates of patient completion of depression symptom screening tools increased significantly in all three regions during the peak pandemic period, and continued to increase during the recovery period. “The transition and subsequent adjustment period have instead been marked by improved adherence to measurement-based care practices in virtual visits, signaling a potential new capacity for virtual health care delivery,” the researchers write.
In contrast to the conditions evaluated in other KP studies, behavioral health for major depression continued to be delivered predominantly through telemedicine during the pandemic recovery period. Dr. Weinfield and coauthors conclude: “Within these three regions of KP, the fact that care has not rebounded to include substantial in-person visits suggests that virtual visits have proven to be a successful model for providers and patients.”
Read [Health-care–Related Practices in Virtual Behavioral Health Treatment for Major Depression Before and During the COVID-19 Pandemic]
Wolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students in effective decision-making and outcomes across healthcare. We support clinical effectiveness, learning and research, clinical surveillance and compliance, as well as data solutions. For more information about our solutions, visit https://www.wolterskluwer.com/en/health and follow us on LinkedIn and Twitter @WKHealth.
About Medical Care
Rated as one of the top ten journals in health care administration, Medical Care is devoted to all aspects of the administration and delivery of health care. This scholarly journal publishes original, peer-reviewed papers documenting the most current developments in the rapidly changing field of health care. Medical Care provides timely reports on the findings of original investigations into issues related to the research, planning, organization, financing, provision, and evaluation of health services. In addition, numerous special supplementary issues that focus on specialized topics are produced with each volume. Medical Care is the official journal of the Medical Care Section of the American Public Health Association.
About Wolters Kluwer
Wolters Kluwer (WKL) is a global leader in professional information, software solutions, and services for the healthcare; tax and accounting; governance, risk and compliance; and legal and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with specialized technology and services.
Wolters Kluwer reported 2021 annual revenues of €4.8 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 20,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.
For more information, visit www.wolterskluwer.com, follow us on LinkedIn, Twitter, Facebook, and YouTube.